XML 30 R18.htm IDEA: XBRL DOCUMENT
v3.24.1.u1

Net Income (Loss) Per Common Share | 3 Months Ended
--- | ---
Mar. 31, 2024
Earnings Per Share [Abstract] |
Net Income (Loss) Per Common Share | Net Loss Per Common Share The following table summarizes the computation of basic and diluted net loss per common share.
| Three Months Ended March 31, |  |
| 2024 |  | 2023 |  |  |  |
Numerator: |  |  |  |  |  |  |
Net loss | $ | (12,537) |  |  | $ | (10,175) |  |  |  |  |
Adjustment for preferred stock cumulative dividends and deemed dividends | (3,670) |  |  | (3,051) |  |  |  |  |
Numerator for basic and diluted net loss per common share | $ | (16,207) |  |  | $ | (13,226) |  |  |  |  |
Denominator: |  |  |  |  |  |  |
Weighted average common shares outstanding | 48,488 |  |  | 43,847 |  |  |  |  |
Adjustment for participating securities | (3,454) |  |  | (742) |  |  |  |  |
Adjustment for warrants outstanding (1) | 2,690 |  |  | 2,204 |  |  |  |  |
Shares used to calculate basic and diluted net loss per share | 47,724 |  |  | 45,309 |  |  |  |  |
Basic and diluted net loss per common share | $ | (0.34) |  |  | $ | (0.29) |  |  |  |  |
Cash dividends declared per common share | $ | — |  |  | $ | — |  |  |  |  |
_______________________________ (1) Outstanding warrants that are exercisable at an exercise price of $0.01 per share, are included in shares outstanding for calculation of basic earnings per share (see Note 15). The following table presents securities that could be potentially dilutive in the future that were excluded from the calculation of diluted net loss per common share because they had an anti-dilutive effect.
| Three Months Ended March 31, |  |
| 2024 |  | 2023 |  |  |  |
Stock Options | 257 |  |  | 516 |  |  |  |  |
2019 Warrants | 1,500 |  |  | 1,500 |  |  |  |  |
Performance share units | 268 |  |  | — |  |  |  |  |
Total antidilutive securities | 2,025 |  |  | 2,016 |  |  |  |  |
Stock options excluded from the calculations of diluted net loss per share had a per share exercise price ranging from $7.93 to $25.16 for the three months ended March 31, 2024. The 2019 Warrants excluded from the calculation of diluted net loss per share had a per share exercise price of $11.03. Performance share units are potentially dilutive when the related performance criterion has been met.

X
- References No definition available. + Details
Name: | us-gaap_EarningsPerShareAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for earnings per share. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org//260/tableOfContent Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482662/260-10-50-2 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482662/260-10-50-3 + Details
Name: | us-gaap_EarningsPerShareTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration